(Q43960808)

28 November 2017

title

Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy (English)

1 reference

adaptive radiation therapy

28 November 2017

main subject

0 references

1 reference

4

L Douglas Case

1 reference

28 November 2017

Richard P McQuellon

1

1 reference

28 November 2017

Dawn B Moose

2

1 reference

28 November 2017

Gregory B Russell

3

1 reference

28 November 2017

Katherine Greven

5

1 reference

28 November 2017

Michael Stevens

6

1 reference

28 November 2017

Edward G Shaw

7

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

International Journal of Radiation Oncology Biology Physics

28 November 2017

published in

1 reference

28 November 2017

volume

52

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

1180-1185

1 reference

Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

Geriatric cachexia: the role of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

On appetite and its loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

Quality of life in cancer: definition, purpose, and method of measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

Nutrition and hydration in the terminally ill cancer patient: the nurse's role in helping patients and families cope

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902782-1

7 January 2021

10.1016/S0360-3016(01)02782-1

Identifiers

DOI

1 reference

28 November 2017

1 reference